In Silico Analysis

IPA’s in silico developability profiling toolset includes sequence analysis, Fv model-based structure analysis, and Fv model-based surface analysis for antibody lead candidates to identify e.g. chemical liability motifs, aggregation prone regions, and charge properties. These in silico engineering approaches facilitate focused antibody de-risking, if required, to improve the mAb developability profile.